General Healthcare News
Will Not Using Image Analysis in Pathology be Perceived as Irrespon...
- Advocacy
- Anatomic Pathology
- Blogs
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- TeleHealth
- Web/Tech
- Whole slide
Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com. It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...
Register now for Molecular Med Tri-Con 2017. Inspirata will provide the keys to unlock Precision Medicine through Digital Pathology at the Molecular Medicine Tri-Conference. Attend their presentations from Dr. Mark Boguski and Dr. Mark Lloyd....
Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement...
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...
This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris. But same day...
In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...






























